{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:41:32Z","timestamp":1788932492035,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI028433, R01-AI150500, P01-AI131365"],"award-info":[{"award-number":["R01-AI028433, R01-AI150500, P01-AI131365"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>VRC01 is a broadly neutralizing antibody that targets the CD4 binding site of HIV-1 gp120. Passive administration of VRC01 in humans has assessed the safety and the effect on plasma viremia of this monoclonal antibody (mAb) in a phase 1 clinical trial. After VRC01 infusion, the plasma viral load in most of the participants was reduced but had particular dynamics not observed during antiretroviral therapy. In this paper, we introduce different mathematical models to explain the observed dynamics and fit them to the plasma viral load data. Based on the fitting results we argue that a model containing reversible Ab binding to virions and clearance of virus-VRC01 complexes by a two-step process that includes (1) saturable capture followed by (2) internalization\/degradation by phagocytes, best explains the data. This model predicts that VRC01 may enhance the clearance of Ab-virus complexes, explaining the initial viral decay observed immediately after antibody infusion in some participants. Because Ab-virus complexes are assumed to be unable to infect cells, i.e., contain neutralized virus, the model predicts a longer-term viral decay consistent with that observed in the VRC01 treated participants. By assuming a homogeneous viral population sensitive to VRC01, the model provides good fits to all of the participant data. However, the fits are improved by assuming that there were two populations of virus, one more susceptible to antibody-mediated neutralization than the other.<\/jats:p>","DOI":"10.3389\/fimmu.2021.710012","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:48:02Z","timestamp":1630705682000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Modeling HIV-1 Within-Host Dynamics After Passive Infusion of the Broadly Neutralizing Antibody VRC01"],"prefix":"10.3389","volume":"12","author":[{"given":"E. Fabian","family":"Cardozo-Ojeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Perelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"319ra206","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic Effects of Broadly Neutralizing Antibody VRC01 Administration During Chronic HIV-1 Infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci Trans Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature12744","article-title":"Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature14411","article-title":"Viraemia Suppressed in HIV-1-Infected Humans by Broadly Neutralizing Antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00754-11","article-title":"Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01","volume":"85","author":"Li","year":"2011","journal-title":"J Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1192819","article-title":"Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies","volume":"39","author":"Zhou","year":"2013","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature05580","article-title":"Structural Definition of a Conserved Neutralization Epitope on HIV-1 Gp120","volume":"445","author":"Zhou","year":"2007","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/cei.12692","article-title":"Safety, Pharmacokinetics and Neutralization of the Broadly Neutralizing HIV-1 Human Monoclonal Antibody VRC01 in Healthy Adults","volume":"182","author":"Ledgerwood","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000843","article-title":"Early HIV RNA Decay During Raltegravir-Containing Regimens Exhibits Two Distinct Subphases (1a and 1b)","volume":"29","author":"Andrade","year":"2015","journal-title":"AIDS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 Dynamics In Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time","volume":"271","author":"Perelson","year":"1996","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-Gp41 Antibodies With Ineffective Control of Initial Viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1003730","DOI":"10.1371\/journal.pcbi.1003730","article-title":"Antibody Responses During Hepatitis B Viral Infection","volume":"10","author":"Ciupe","year":"2014","journal-title":"PloS Comput Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jtbi.2011.01.050","article-title":"Paradoxical Suppression of Poly-Specific Broadly Neutralizing Antibodies in the Presence of Strain-Specific Neutralizing Antibodies Following HIV Infection","volume":"277","author":"Ciupe","year":"2011","journal-title":"J Theoret Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e100598","DOI":"10.1371\/journal.pone.0100598","article-title":"Modeling Neutralization Kinetics of HIV by Broadly Neutralizing Monoclonal Antibodies in Genital Secretions Coating the Cervicovaginal Mucosa","volume":"9","author":"McKinley","year":"2014","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced Clearance of HIV-1\u2013Infected Cells by Broadly Neutralizing Antibodies Against HIV-1 In Vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1773-1779.2006","article-title":"Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) Against Human Immunodeficiency Virus Type 1 Envelope Gp120 (MAb 2G12) and Gp41 (MAbs 4E10 and 2F5)","volume":"50","author":"Joos","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"B17","volume-title":"Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications","author":"Gabrielsson","year":"2001"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.8.5037-5038.2003","article-title":"A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo","volume":"77","author":"Markowitz","year":"2003","journal-title":"J Virol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1741-7007-11-96","article-title":"Modeling the Within-Host Dynamics of HIV Infection","volume":"11","author":"Perelson","year":"2013","journal-title":"BMC Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling Viral and Immune System Dynamics","volume":"2","author":"Perelson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/387188a0","article-title":"Decay Characteristics of HIV-1-Infected Compartments During Combination Therapy","volume":"387","author":"Perelson","year":"1997","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e40198","DOI":"10.1371\/journal.pone.0040198","article-title":"HIV Model Parameter Estimates From Interruption Trial Data Including Drug Efficacy and Reservoir Dynamics","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2010.11.001","article-title":"Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue","volume":"143","author":"Doitsh","year":"2010","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature12940","article-title":"Cell Death by Pyroptosis Drives CD4 T-Cell Depletion in HIV-1 Infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1419162112","article-title":"Post-Treatment Control of HIV Infection","volume":"112","author":"Conway","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200010200-00012","article-title":"Risks and Benefits of Structured Antiretroviral Drug Therapy Interruptions in HIV-1 Infection","volume":"14","author":"Bonhoeffer","year":"2000","journal-title":"AIDS"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00306-16","article-title":"Notwithstanding Circumstantial Alibis, Cytotoxic T Cells can be Major Killers of HIV-1-Infected Cells","volume":"90","author":"Gadhamsetty","year":"2016","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000199233.69457.e4","article-title":"Density-Dependent Decay in HIV-1 Dynamics","volume":"41","author":"Holte","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00394-06","article-title":"Rapid Viral Decay in Simian Immunodeficiency Virus-Infected Macaques Receiving Quadruple Antiretroviral Therapy","volume":"80","author":"Brandin","year":"2006","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02035-8","article-title":"Rapid Production and Clearance of HIV-1 and Hepatitis C Virus Assessed by Large Volume Plasma Apheresis","volume":"354","author":"Ramratnam","year":"1999","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.9.1277","article-title":"Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy","volume":"194","author":"Mohri","year":"2001","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1187659","article-title":"Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1207227","article-title":"Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05095-11","article-title":"Timing of the Components of the HIV Life Cycle in Productively Infected CD4+ T Cells in a Population of HIV-Infected Individuals","volume":"85","author":"Murray","year":"2011","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.98.4.1170","article-title":"Internalization and Degradation of Macrophage Fc Receptors Bound to Polyvalent Immune Complexes","volume":"98","author":"Mellman","year":"1984","journal-title":"J Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.03.012","article-title":"Decreased Fc Receptor Expression on Innate Immune Cells is Associated With Impaired Antibody-Mediated Cellular Phagocytic Activity in Chronically HIV-1 Infected Individuals","volume":"415","author":"Dugast","year":"2011","journal-title":"Virology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.009","article-title":"Antibody Effector Functions Mediated by Fcgamma-Receptors Are Compromised During Persistent Viral Infection","volume":"42","author":"Wieland","year":"2015","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.005","article-title":"Suppression of Fcgamma-Receptor-Mediated Antibody Effector Function During Persistent Viral Infection","author":"Yamada Douglas","year":"2015","journal-title":"Immunity"},{"key":"B39","first-page":"488","volume-title":"Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach","author":"Burnham","year":"2003"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e1006478","DOI":"10.1371\/journal.ppat.1006478","article-title":"Treatment With Integrase Inhibitor Suggests a New Interpretation of HIV RNA Decay Curves That Reveals a Subset of Cells With Slow Integration","volume":"13","author":"Cardozo","year":"2017","journal-title":"PLoS Pathog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/5576","article-title":"Human Immunodeficiency Virus Type 1 Neutralizing Antibodies Accelerate Clearance of Cell\u2013Free Virions From Blood Plasma","volume":"5","author":"Igarashi","year":"1999","journal-title":"Nat Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.023","article-title":"Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity","volume":"158","author":"Bournazos","year":"2014","journal-title":"Cell"},{"key":"B43","volume-title":"Immunobiology","author":"Janeway","year":"2001"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.10.6274","article-title":"Involvement of Fc\u03b3RI (CD64) in the Mechanism of HIV-1 Inhibition by Polyclonal IgG Purified From Infected Patients in Cultured Monocyte-Derived Macrophages","volume":"173","author":"Holl","year":"2004","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.12","article-title":"Fc Receptor-Mediated Phagocytosis in Tissues as a Potent Mechanism for Preventive and Therapeutic HIV Vaccine Strategies","volume":"9","author":"Sips","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 Suppresses Viremia in HIV-1-Infected Individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/156652410793384141","article-title":"Monocyte and Macrophage Dysfunction as a Cause of HIV-1 Induced Dysfunction of Innate Immunity","volume":"10","author":"Collini","year":"2010","journal-title":"Curr Mol Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12516","article-title":"Proteomics Approach to Understand Reduced Clearance of Mycobacteria and High Viral Titers During HIV\u2013mycobacteria Co-Infection","volume":"18","author":"Ganji","year":"2016","journal-title":"Cell Microbiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.127","article-title":"Small Alveolar Macrophages are Infected Preferentially by HIV and Exhibit Impaired Phagocytic Function","volume":"7","author":"Jambo","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.9.5.983-986.2002","article-title":"Impaired Macrophage Phagocytosis of Apoptotic Neutrophils in Patients With Human Immunodeficiency Virus Type 1 Infection","volume":"9","author":"Torre","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1038\/ncomms7211","article-title":"HIV-1 Tat Inhibits Phagocytosis by Preventing the Recruitment of Cdc42 to the Phagocytic Cup","volume":"6","author":"Debaisieux","year":"2015","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-259473","article-title":"Inhibition of Phagocytosis in HIV-1\u2013Infected Macrophages Relies on Nef-Dependent Alteration of Focal Delivery of Recycling Compartments","volume":"115","author":"Mazzolini","year":"2010","journal-title":"Blood"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201503124","article-title":"The HIV-1 Protein Vpr Impairs Phagosome Maturation by Controlling Microtubule-Dependent Trafficking","volume":"211","author":"Dumas","year":"2015","journal-title":"J Cell Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.55.2.147","article-title":"A Single Assay for Measuring the Rates of Phagocytosis and Bacterial Killing by Neutrophils","volume":"55","author":"Hampton","year":"1994","journal-title":"J Leukoc Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2002.01460.x","article-title":"Macrophage Phagocytosis of Foot-and-Mouth Disease Virus May Create Infectious Carriers","volume":"106","author":"Rigden","year":"2002","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/bulm.2001.0266","article-title":"HIV-1 Infection and Low Steady State Viral Loads","volume":"64","author":"Callaway","year":"2002","journal-title":"Bull Math Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1137\/090757009","article-title":"On Identifiability of Nonlinear ODE Models and Applications in Viral Dynamics","volume":"53","author":"Miao","year":"2011","journal-title":"SIAM Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/jtbi.2000.1076","article-title":"Modeling Plasma Virus Concentration During Primary HIV Infection","volume":"203","author":"Stafford","year":"2000","journal-title":"J Theoret Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.3.2271-2275.2003","article-title":"In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays From 50 to <5 Copies Per Milliliter, With a Half-Life of 6 Months","volume":"77","author":"Di Mascio","year":"2003","journal-title":"J Virol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"20130186","DOI":"10.1098\/rsif.2013.0186","article-title":"Modelling HIV-1 2-LTR Dynamics Following Raltegravir Intensification","volume":"10","author":"Luo","year":"2013","journal-title":"J Roy Soc Interface"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01254-12","article-title":"Modeling Uncertainty in Single-Copy Assays for HIV","volume":"50","author":"Luo","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.710012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:48:07Z","timestamp":1630705687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.710012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2021.710012"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.710012","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]},"article-number":"710012"}}